Highlighting important stories that challenge the status quo and inspire positive change in society is one of the most important aspects of a documentarian’s career. Filmmakers Brendan Fitzgerald and Drea Bernardi are courageously taking on that challenge with their new movie, ‘The Oxy Kingpins,’ which is bringing context to one of the most complex issues […]
The post SXSW 2021 Interview: Brendan Fitzgerald and Drea Bernard Talk The Oxy Kingpins (Exclusive) appeared first on Shockya.com.
The post SXSW 2021 Interview: Brendan Fitzgerald and Drea Bernard Talk The Oxy Kingpins (Exclusive) appeared first on Shockya.com.
- 4/12/2021
- by Karen Benardello
- ShockYa
“The Oxy Kingpins” is a documentary that feels like it could be a Martin Scorsese movie. It’s “The Wolf of Wall Street” meets “The Insider” — the story of a scurrilous illegal business, and one of the hotshot thrill junkies who rode it to riches, and how that business connects up to a much larger corporate racket. The big players, in this case, are the pharmaceutical distribution companies that dumped opioids onto the market, addicting countless people to OxyContin, a narcotic painkiller that’s really heroin with a “medical” image brand. The thrill junkie is Alex Dimattio, a drug dealer who grew up in New York City, where he dealt weed in Washington Square Park and heroin on the Lower East Side, only to discover that he could make a killing (with a lot less risk) by selling OxyContin pills.
You may think that you already know the ins and outs of the opioid crisis.
You may think that you already know the ins and outs of the opioid crisis.
- 3/27/2021
- by Owen Gleiberman
- Variety Film + TV
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.